Elham Hershberger - Jan 30, 2022 Form 4 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Role
Chief Development Officer
Signature
/s/ Jane Pritchett Henderson, Attorney-in-Fact
Stock symbol
IVVD
Transactions as of
Jan 30, 2022
Transactions value $
$0
Form type
4
Date filed
2/1/2022, 05:18 PM
Previous filing
Aug 5, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IVVD Stock Option (Right to Buy) Award $0 +175K $0.00 175K Jan 30, 2022 Common Stock 175K $6.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal monthly installments over a four-year period measured from one month following January 30, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.